Search results
The PPD™ clinical research business of Thermo Fisher Scientific is a global contract research organization (CRO) delivering clinical expertise for your product's success. Learn more about our life changing therapies.
Pharmaceutical Product Development (PPD) is a global contract research organization (CRO) providing comprehensive, integrated drug development, laboratory and lifecycle management services. In December 2021, PPD became a wholly owned subsidiary of Thermo Fisher Scientific .
We provide comprehensive drug development, laboratory and lifecycle services to customers across pharmaceutical, biotechnology, medical device, academic and government entities. By harnessing innovative technology and expertise, we work to empower our customers to bring therapies to market, faster.
Dec 8, 2021 · Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has completed its acquisition of PPD, Inc. (Nasdaq: PPD), a leading global provider of clinical research services to the biopharma and biotech industry, for $17.4 billion.
PPD™ Laboratory services support pharmaceutical development for companies of any size. Leveraging our extensive capabilities and scientific expertise, we deliver outstanding project management and provide high-quality data that meet regulatory requirements.
Apr 15, 2021 · PPD is a leading global clinical research organization providing broad, integrated drug development, laboratory and lifecycle management services. Our customers include pharmaceutical, biotechnology, medical device, academic and government organizations.
Helping deliver life-changing therapies | PPD is part of Thermo Fisher Scientific, the world leader in serving science. Together, Thermo Fisher and its PPD clinical research business are...
